FierceBiotech The non-profit DRIVE, described as a self-sustaining public/private venture, will recruit a business team to take some of the most innovative drug discovery work at the university, put it through pre-clinical testing and on to proof-of-concept studies ... and more »
News-Medical.net Emory University today announced an innovative new public-private drug development enterprise that will transition scientific discoveries more rapidly and efficiently from university laboratories into the marketplace. The new venture is expected to ...
News-Medical.net Emory University today announced an innovative new public-private drug development enterprise that will transition scientific discoveries more rapidly and efficiently from university laboratories into the marketplace. The new venture is expected to ... and more »
NASDAQ But the FDA's new breakthrough status isn't just a win for drug companies and the health care industry -- it's also creating an opportunity to invest in the most innovative companies in the world. The companies winning breakthrough status for their ... and more »
National Post “It's an exciting moment for the entire NPS team, which has achieved so much and works so hard each and every day to bring innovative therapeutics to patients suffering from rare diseases around the world.” Dr. Nader joined NPS in 2006 and was ... and more »
SBWire (press release) This comprehensive report includes statistics on value and volume of the overall regional CE market and zeroes in on the specifics of the generic and innovative drug segments in each of six Central European countries: Poland, Romania, Slovakia, the ...
Financial Post The Minister of Health refused to grant data protection to Takeda on the basis that Dexilant was a variation of a previously approved drug because it was an enantiomer (a non-identical mirror image) of a previously approved drug, lansoprazole . “The FCA ...
